Home The Word Brain | My Amedeo FAQ Privacy About | ||||||||||
The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al. |
Cervical Cancer |
Single Articles |
AMEDEO Cervical Cancer is free of charge.
Tumor and metastatic lymph nodes metabolic activity on (18)F-FDG-PET/CT to
predict progression-free survival in locally advanced cervical cancer.
Abdom Radiol (NY). 2024 Feb 1. doi: 10.1007/s00261-023-04158.
PubMed
Abstract available
Cervix cytology samples revealed increased methylation of the human markers
FAM19A4/miR124-2 up to 8 years before adenocarcinoma.
Acta Obstet Gynecol Scand. 2024;103:378-386.
PubMed
Abstract available
Insights into the mechanisms and structure of breakage-fusion-bridge cycles in
cervical cancer using long-read sequencing.
Am J Hum Genet. 2024 Jan 25:S0002-9297(24)00002.
PubMed
Abstract available
Comparing the performance of two HPV assays for a new use indication: a
real-world evidence-based evaluation in the United States.
Am J Obstet Gynecol. 2023 Oct 6:S0002-9378(23)00730.
PubMed
Abstract available
Cervical Cancer Therapeutics: An In-depth Significance of Herbal and Chemical
Approaches of Nanoparticles.
Anticancer Agents Med Chem. 2024.
PubMed
Abstract available
Prevalence of PD-L1 in Cervical Cancer Patients and the Potential for Combining
an Immune Checkpoint Inhibitor With Lenvatinib.
Anticancer Res. 2024;44:503-510.
PubMed
Abstract available
Comparative Analysis of VMAT and IMRT Techniques: Evaluation of Dose Constraints
and Bone Marrow Sparing in Cervical Cancer Patients Undergoing Chemoradiotherapy.
Asian Pac J Cancer Prev. 2024;25:139-144.
PubMed
Abstract available
Clinical Performance of Self-collected Specimen HPV-DNA vs Clinician- collected
Specimen HPV-mRNA to Detect High-risk HPV and High-grade Cervical Lesions and
Cancer.
Asian Pac J Cancer Prev. 2024;25:211-217.
PubMed
Abstract available
E7-mediated repression of miR-203 promotes LASP1-dependent proliferation in
HPV-positive cervical cancer.
bioRxiv. 2024 Jan 15:2024.01.08.574687. doi: 10.1101/2024.01.08.574687.
PubMed
Abstract available
Retraction: LINC00636 promotes lymph node metastasis and of cervical cancer
through target NM23.
Biosci Rep. 2024;44:BSR-2020-0367.
PubMed
Gefitinib induces anoikis in cervical cancer cells.
BMB Rep. 2024 Feb 5:6127.
PubMed
Abstract available
Development and validation of a (18)F-FDG PET/CT radiomics nomogram for
predicting progression free survival in locally advanced cervical cancer: a
retrospective multicenter study.
BMC Cancer. 2024;24:150.
PubMed
Abstract available
Sociodemographic characteristics and their association with survival in women
with cervical cancer.
BMC Cancer. 2024;24:161.
PubMed
Abstract available
Acetylmelodorinol isolated from Sphaerocoryne affinis seeds inhibits cell
proliferation and activates apoptosis on HeLa cells.
BMC Complement Med Ther. 2024;24:59.
PubMed
Abstract available
Performance of node reporting and data system (node-RADS): a preliminary study in
cervical cancer.
BMC Med Imaging. 2024;24:28.
PubMed
Abstract available
Factors influencing cervical cancer re-screening in a semi-rural health district
of Cameroon: a cohort study.
BMC Womens Health. 2024;24:76.
PubMed
Abstract available
Effect of marital status on the survival outcomes of cervical cancer: a
retrospective cohort study based on SEER database.
BMC Womens Health. 2024;24:75.
PubMed
Abstract available
Prediction of recurrence-related factors for patients with early-stage cervical
cancer following radical hysterectomy and adjuvant radiotherapy.
BMC Womens Health. 2024;24:81.
PubMed
Abstract available
Global, regional, and national quality of care index of cervical and ovarian
cancer: a systematic analysis for the global burden of disease study 1990-2019.
BMC Womens Health. 2024;24:69.
PubMed
Abstract available
Post-radiation uterine rhabdomyosarcoma.
BMJ Case Rep. 2024;17:e258853.
PubMed
Phase 1/2 trial of avelumab combined with utomilumab (4-1BB agonist), PF-04518600
(OX40 agonist), or radiotherapy in patients with advanced gynecologic
malignancies.
Cancer. 2023 Oct 21. doi: 10.1002/cncr.35063.
PubMed
Abstract available
Breast and cervical cancer screenings across gender identity: results from the
Behavioral Risk Factor Surveillance System before and during the COVID-19
pandemic.
Cancer Causes Control. 2024 Jan 27. doi: 10.1007/s10552-023-01847.
PubMed
Abstract available
Associations between sociodemographic factors and breast, cervical, and
colorectal cancer screening in the United States.
Cancer Causes Control. 2023;34:1073-1084.
PubMed
Abstract available
Identification of target cells of human papillomavirus 18 using squamocolumnar
junction organoids.
Cancer Sci. 2024;115:125-138.
PubMed
Abstract available
An engineered Accum-E7 protein-based vaccine with dual anti-cervical cancer
activity.
Cancer Sci. 2024 Jan 29. doi: 10.1111/cas.16096.
PubMed
Abstract available
Transcriptome sequencing analysis reveals miR-30c-5p promotes ferroptosis in
cervical cancer and inhibits growth and metastasis of cervical cancer xenografts
by targeting the METTL3/KRAS axis.
Cell Signal. 2024 Jan 27:111068. doi: 10.1016/j.cellsig.2024.111068.
PubMed
Abstract available
Predictive Role of Preoperative Whole-Body 18F-FDG PET/CT for Risk Stratification
of Early-Stage (FIGO I-IIA) Cervical Cancer Patients Treated by Surgery.
Cureus. 2024;16:e53107.
PubMed
Abstract available
Factors Associated With the Uptake of Cervical Cancer Screening Among Family
Medicine Physicians, Compared With Women of the Community in Riyadh, Saudi
Arabia.
Cureus. 2024;16:e53283.
PubMed
Abstract available
Targeting Cervical Cancer Stem Cells by Phytochemicals.
Curr Med Chem. 2024 Jan 29. doi: 10.2174/0109298673281823231222065616.
PubMed
Abstract available
Our experience diagnosing 225 patients with cervical glandular lesions: current
technologies, lessons learned, and areas for improvement.
Diagn Pathol. 2024;19:22.
PubMed
Abstract available
EuroMed Cancer Network contributions to eliminating cervical cancer in low- and
middle-income Mediterranean countries.
East Mediterr Health J. 2023;26:894-902.
PubMed
Abstract available
Retracted: Analysis of the Clinical Value of MAGE-A9 Expressions in Cervical
Cancer Tissues and PBMC.
Emerg Med Int. 2024;2024:9758570.
PubMed
Abstract available
Impact of altering the invitation package on screening participation among
never-screeners in the Flemish population-based cancer screening programs.
Eur J Cancer Prev. 2024;33:181-184.
PubMed
Abstract available
Is phased implementation of HPV testing and triage with dual staining the way to
transform organized cytology screening?
Eur J Cancer Prev. 2024;33:168-176.
PubMed
Abstract available
Eur J Obstet Gynecol Reprod Biol
Immunohistochemical markers Ki67 and P16 help predict prognosis in locally
advanced cervical cancer.
Eur J Obstet Gynecol Reprod Biol. 2024;294:210-216.
PubMed
Abstract available
Serum squamous cell carcinoma antigen level and magnetic resonance imaging for
the prognosis of locally advanced cervical cancer.
Eur Rev Med Pharmacol Sci. 2024;28:668-678.
PubMed
Abstract available
Pterostilbene upregulates MICA/B via the PI3K/AKT signaling pathway to enhance
the capability of natural killer cells to kill cervical cancer cells.
Exp Cell Res. 2024;435:113933.
PubMed
Abstract available
The m6A methyltransferase RBM15 affects tumor cell stemness and progression of
cervical cancer by regulating the stability of lncRNA HEIH.
Exp Cell Res. 2024 Jan 25:113924. doi: 10.1016/j.yexcr.2024.113924.
PubMed
Abstract available
Exploring conservative management for cervical intraepithelial neoplasia grade 2
in organised cervical cancer screening programmes: a multicentre study in Italy.
Fam Med Community Health. 2024;12.
PubMed
Abstract available
The opposite role of lactate dehydrogenase a (LDHA) in cervical cancer under
energy stress conditions.
Free Radic Biol Med. 2024 Jan 31:S0891-5849(24)00051.
PubMed
Abstract available
Role of SLC5A8 as a Tumor Suppressor in Cervical Cancer.
Front Biosci (Landmark Ed). 2024;29:16.
PubMed
Abstract available
HPV vaccination in Africa in the COVID-19 era: a cross-sectional survey of
healthcare providers' knowledge, training, and recommendation practices.
Front Public Health. 2024;12:1343064.
PubMed
Abstract available
Exploring Immune-Related Gene Profiling and Infiltration of Immune Cells in
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Genes (Basel). 2024;15:121.
PubMed
Abstract available
EGLN1: A Biomarker of Poor Prognosis of Cervical Cancer and a Target of
Treatment.
Genet Test Mol Biomarkers. 2024;28:10-21.
PubMed
Abstract available
Variation in cervical cancer screening test utilization and results in a United
States-based program.
Gynecol Oncol. 2024;184:96-102.
PubMed
Abstract available
Calendar-period trends in cervical precancer and cancer diagnoses since the
introduction of human papillomavirus and cytology co-testing into routine
cervical cancer screening at Kaiser Permanente Northern California.
Gynecol Oncol. 2024;184:89-95.
PubMed
Abstract available
Anti-tumor effect and mechanism of the total biflavonoid extract from S
doederleinii on human cervical cancer cells in vitro and in vivo.
Heliyon. 2024;10:e24778.
PubMed
Abstract available
HIF-1A as a prognostic biomarker related to invasion, migration and
immunosuppression of cervical cancer.
Heliyon. 2024;10:e24664.
PubMed
Abstract available
Chemotherapy alone versus chemotherapy plus (125)I brachytherapy for the
second-line treatment of locally recurrent cervical cancer after/with radical
treatment: A propensity score analysis.
Heliyon. 2024;10:e24666.
PubMed
Abstract available
NUPR1 contributes to activate TFE3-dependent autophagy leading to cervical cancer
proliferation.
Heliyon. 2024;10:e24408.
PubMed
Abstract available
Overview of Human Papillomavirus Infection.
Infect Disord Drug Targets. 2024;24:e031123223107.
PubMed
Abstract available
Predictive Value of Various Atypical Cells for the Detection of Human
Papillomavirus in Cervical Smears.
Int J Mol Sci. 2024;25:1212.
PubMed
Abstract available
TNF-alpha-induced down-regulation of type I interferon receptor contributes to
acquired resistance of cervical squamous cancer to Cisplatin.
J Antibiot (Tokyo). 2024;77:102-110.
PubMed
Abstract available
A visualization analysis of hotspots and global trends on pelvic floor
dysfunction in cervical cancer.
J Cancer Res Clin Oncol. 2024;150:54.
PubMed
Abstract available
The establishment of a multiplex fluorescent polymerase chain reaction coupled
with capillary electrophoresis analysis technology enables the simultaneous
detection of 16 genotypes of human papillomavirus.
J Clin Lab Anal. 2024;38.
PubMed
Abstract available
Lactylation stabilizes DCBLD1 activating the pentose phosphate pathway to promote
cervical cancer progression.
J Exp Clin Cancer Res. 2024;43:36.
PubMed
Abstract available
Evolving standards and future directions for systemic therapies in cervical
cancer.
J Gynecol Oncol. 2024 Jan 15. doi: 10.3802/jgo.2024.
PubMed
Abstract available
Advanced technologies towards improved HPV diagnostics.
J Med Virol. 2024;96:e29409.
PubMed
Abstract available
Knowledge of Cervical Cancer Screening and Prevention by Human Papillomavirus
Deoxyribonucleic Acid and Human Papillomavirus Vaccination among Women Attending
a Tertiary Care Centre.
JNMA J Nepal Med Assoc. 2023;61:658-661.
PubMed
Abstract available
Cervical Papanicolaou Smear Test Screening among Patients Visiting the Outpatient
Department of Gynaecology of a Tertiary Care Centre.
JNMA J Nepal Med Assoc. 2023;61:699-702.
PubMed
Abstract available
Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy
of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
Med Oncol. 2024;41:65.
PubMed
Abstract available
Cervical cancer kills 300,000 people a year - here's how to speed up its
elimination.
Nature. 2024;626:30-32.
PubMed
Life Experience of Survivors of Gynecologic Cancers: A Survey Conducted in Italy.
Oncology (Williston Park). 2024;38:15-19.
PubMed
Abstract available
Squamocolumnar junction visibility, age, and implications for cervical cancer
screening programs.
Prev Med. 2024;180:107881.
PubMed
Abstract available
Integrating HPV self-collect into primary care to address cervical cancer
screening disparities.
Prev Med Rep. 2024;38:102599.
PubMed
Abstract available
Factors influencing human papillomavirus vaccination uptake in European women and
adolescents: A systematic review and meta-analysis.
Psychooncology. 2024;33:e6242.
PubMed
Abstract available
Factors affecting cervical screening using the health belief model during the
last decade: A systematic review and meta-analysis.
Psychooncology. 2024;33:e6275.
PubMed
Abstract available
A Novel Eight-Gene Signature for Lipid Metabolism Predicts the Progression of
Cervical Squamous Cell Carcinoma and Endocervical Adenocarcinoma.
Reprod Sci. 2024;31:514-531.
PubMed
Abstract available
Integration of network pharmacology, molecular docking, and simulations to
evaluate phytochemicals from Drymaria cordata against cervical cancer.
RSC Adv. 2024;14:4188-4200.
PubMed
Abstract available
Utilization and associated factors of cervical cancer screening service among
eligible women attending maternal health services at Adare General Hospital,
Hawassa city, Southern Ethiopia.
Sci Rep. 2024;14:2774.
PubMed
Abstract available
Radiochemotherapy and interstitial brachytherapy for cervical cancer: clinical
results and patient-reported outcome measures.
Strahlenther Onkol. 2024 Jan 31. doi: 10.1007/s00066-023-02196.
PubMed
Abstract available
Vaccine and Non-Vaccine HPV Types Presence in Adolescents with Vertically
Acquired HIV Five Years Post Gardasil Quadrivalent Vaccination: The ZIMGARD
Cohort.
Viruses. 2024;16:162.
PubMed
Abstract available
CONTEXTUAL FACTORS ASSOCIATED WITH CERVICAL CANCER.
Wiad Lek. 2023;76:2687-2693.
PubMed
Abstract available
Knowledge, attitude, and practices regarding human papilloma virus vaccination
among physicians in Qatar.
Womens Health (Lond). 2024;20:17455057241227360.
PubMed
Abstract available
Thank you for your interest in scientific medicine.